Lawrence Remmel

Larry works with companies from the biotechnology, cosmeceutical, financial services and entertainment industries, as well as with various private equity funds and groups of investors from the U.S. and abroad. He regularly represents JPMorgan Chase Bank, N.A. and Marina Biotech, Inc. He offers extensive knowledge and experience in:

• Investment Company Act of 1940 transactions
• Banking, film and real estate financings
• Licensing deals
• Asset and other securitizations
• Acquisition financing
• Asset-based and mezzanine lending
• Syndications

Delivering Forward-Thinking Solutions

Known for his innovative counsel and deep knowledge of financial instruments, Larry helps clients structure creative solutions to address complex financing challenges. For example, he advised on the development of a novel means of securitizing pharmaceutical royalty cash flows known as Securitized Unregistered Bio-Technology Limited Enhanced™ units.

Larry’s notable transactions include:

• Advising on the conceptualization, development and consummation of the first multinational, multijurisdictional investment company syndicated and agented credit facility
• Advising the sole lender in a $85 million facility to a pool of real estate assets issued by U.S. and foreign issuers
• Negotiating multiple technology licensing agreements for a leading biotechnology company
• Structuring off-balance-sheet studio financing for a renewable slate of films
• Providing startup counsel to the New Ventures Fund I, a biotech private equity fund that invests in late-stage biotechnology companies

Larry also serves in numerous director and board positions within the life sciences space, including CytoDel, Inc., an early stage bio-pharmaceutical company developing products for bio-defense, neuronal drug delivery, and musculoskeletal and aesthetic medicine; Aufbau Holdings Limited, an Irish limited company, developing therapeutics in ophthalmology and other areas; and Atossa Therapeutics Inc. (NASDAQ: ATOS), a company developing therapies for breast cancer.